BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Magouliotis DE, Tasiopoulou VS, Svokos AA, Svokos KA, Chatedaki C, Sioka E, Zacharoulis D. Ursodeoxycholic Acid in the Prevention of Gallstone Formation After Bariatric Surgery: an Updated Systematic Review and Meta-analysis. Obes Surg 2017;27:3021-30. [PMID: 28889240 DOI: 10.1007/s11695-017-2924-y] [Cited by in Crossref: 38] [Cited by in F6Publishing: 31] [Article Influence: 9.5] [Reference Citation Analysis]
Number Citing Articles
1 Wu L, Wang Y, Zhu S, Bao X, Fu Z, Zhen T, Yuan Z, Li Q, Deng Z, Sun J, Chen T. Changes in plasma bile acids are associated with gallbladder stones and polyps. BMC Gastroenterol 2020;20:363. [PMID: 33129276 DOI: 10.1186/s12876-020-01512-8] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Di Ciaula A, Wang DQ, Portincasa P. Cholesterol cholelithiasis: part of a systemic metabolic disease, prone to primary prevention. Expert Rev Gastroenterol Hepatol 2019;13:157-71. [PMID: 30791781 DOI: 10.1080/17474124.2019.1549988] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
3 Di Ciaula A, Portincasa P. Recent advances in understanding and managing cholesterol gallstones. F1000Res. 2018;7. [PMID: 30345010 DOI: 10.12688/f1000research.15505.1] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
4 Della Penna A, Lange J, Hilbert J, Archid R, Königsrainer A, Quante M. Ursodeoxycholic Acid for 6 Months After Bariatric Surgery Is Impacting Gallstone Associated Morbidity in Patients with Preoperative Asymptomatic Gallstones. OBES SURG 2019;29:1216-21. [DOI: 10.1007/s11695-018-03651-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
5 Leyva-Alvizo A, Arredondo-Saldaña G, Leal-Isla-Flores V, Romanelli J, Sudan R, Gibbs KE, Petrick A, Soriano IS; ASMBS Foregut Committee. Systematic review of management of gallbladder disease in patients undergoing minimally invasive bariatric surgery. Surg Obes Relat Dis 2020;16:158-64. [PMID: 31839526 DOI: 10.1016/j.soard.2019.10.016] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
6 Charles-Nelson A, Lazzati A, Katsahian S. Analysis of Trajectories of Care After Bariatric Surgery Using Data Mining Method and Health Administrative Information Systems. Obes Surg 2020;30:2206-16. [PMID: 32030617 DOI: 10.1007/s11695-020-04430-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
7 Verhoeff K, Mocanu V, Dang J, Switzer NJ, Birch DW, Karmali S. Characterization and Risk Factors for Early Biliary Complications Following Elective Bariatric Surgery: an Mbsaqip Analysis. Obes Surg 2022. [PMID: 35048248 DOI: 10.1007/s11695-022-05914-3] [Reference Citation Analysis]
8 Chen YD, Cai HB, Liu P, Peng Y. Non-surgical treatment of cholesterol gallstones: An update on recent developments. Shijie Huaren Xiaohua Zazhi 2018; 26(25): 1511-1516 [DOI: 10.11569/wcjd.v26.i25.1511] [Reference Citation Analysis]
9 Salman MA, Salman A, Mohamed US, Hussein AM, Ameen MA, Omar HSE, Elewa A, Hamdy A, Elias AA, Tourky M, Helal A, Mahmoud AA, Aljarad F, Moustafa A, Shaaban HE, Nashaat A, Hussein AM, Omar T, Balamoun H. Ursodeoxycholic acid for the prevention of gall stones after laparoscopic sleeve gastrectomy: a prospective controlled study. Surg Endosc 2022. [PMID: 35020052 DOI: 10.1007/s00464-021-08980-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
10 Wan Q, Zhao R, Chen Y, Wang Y, Wu Y, Wu X. Comparison of the incidence of cholelithiasis after sleeve gastrectomy and Roux-en-Y gastric bypass: a meta-analysis. Surg Obes Relat Dis 2021;17:1198-205. [PMID: 33785273 DOI: 10.1016/j.soard.2021.02.003] [Reference Citation Analysis]
11 Di Lorenzo N, Antoniou SA, Batterham RL, Busetto L, Godoroja D, Iossa A, Carrano FM, Agresta F, Alarçon I, Azran C, Bouvy N, Balaguè Ponz C, Buza M, Copaescu C, De Luca M, Dicker D, Di Vincenzo A, Felsenreich DM, Francis NK, Fried M, Gonzalo Prats B, Goitein D, Halford JCG, Herlesova J, Kalogridaki M, Ket H, Morales-Conde S, Piatto G, Prager G, Pruijssers S, Pucci A, Rayman S, Romano E, Sanchez-Cordero S, Vilallonga R, Silecchia G. Clinical practice guidelines of the European Association for Endoscopic Surgery (EAES) on bariatric surgery: update 2020 endorsed by IFSO-EC, EASO and ESPCOP. Surg Endosc 2020;34:2332-58. [PMID: 32328827 DOI: 10.1007/s00464-020-07555-y] [Cited by in Crossref: 42] [Cited by in F6Publishing: 28] [Article Influence: 21.0] [Reference Citation Analysis]
12 Hussan H, Ugbarugba E, Porter K, Noria S, Needleman B, Clinton SK, Conwell DL, Krishna SG. The Type of Bariatric Surgery Impacts the Risk of Acute Pancreatitis: A Nationwide Study. Clin Transl Gastroenterol 2018;9:179. [PMID: 30206217 DOI: 10.1038/s41424-018-0045-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
13 Feng X, Zhu C, Lee S, Gao J, Zhu P, Yamauchi J, Pan C, Singh S, Qu S, Miller R, Monga SP, Peng Y, Dong HH. Depletion of hepatic forkhead box O1 does not affect cholelithiasis in male and female mice. J Biol Chem 2020;295:7003-17. [PMID: 32273342 DOI: 10.1074/jbc.RA119.012272] [Reference Citation Analysis]
14 Vahibe A, Ghanem OM. Comment on: management of gallstone disease prior to and after metabolic surgery: a single-center observational study. Surg Obes Relat Dis 2021:S1550-7289(21)00547-5. [PMID: 34903477 DOI: 10.1016/j.soard.2021.11.014] [Reference Citation Analysis]
15 Fearon NM, Kearns EC, Kennedy CA, Conneely JB, Heneghan HM. The impact of ursodeoxycholic acid on gallstone disease after bariatric surgery: a meta-analysis of randomized control trials. Surg Obes Relat Dis 2021:S1550-7289(21)00487-1. [PMID: 34772614 DOI: 10.1016/j.soard.2021.10.004] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
16 Golzarand M, Toolabi K, Parsaei R, Eskandari Delfan S. Incidence of Symptomatic Cholelithiasis Following Laparoscopic Roux-en-Y Gastric Bypass Is Comparable to Laparoscopic Sleeve Gastrectomy: A Cohort Study. Dig Dis Sci 2021. [PMID: 34783969 DOI: 10.1007/s10620-021-07306-6] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Ouyang H, Mei X, Zhang T, Lu B, Ji L. Ursodeoxycholic acid ameliorates diabetic retinopathy via reducing retinal inflammation and reversing the breakdown of blood-retinal barrier. Eur J Pharmacol 2018;840:20-7. [PMID: 30268667 DOI: 10.1016/j.ejphar.2018.09.027] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
18 Doden HL, Ridlon JM. Microbial Hydroxysteroid Dehydrogenases: From Alpha to Omega. Microorganisms 2021;9:469. [PMID: 33668351 DOI: 10.3390/microorganisms9030469] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
19 Auge M, Menahem B, Savey V, Lee Bion A, Alves A. Long-term complications after gastric bypass and sleeve gastrectomy: What information to give to patients and practitioners, and why? J Visc Surg 2022:S1878-7886(22)00039-X. [PMID: 35304081 DOI: 10.1016/j.jviscsurg.2022.02.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Barzin M, Andalib A, Khalaj A, Mahdavi M, Valizadeh M, Mousapour P, Hosseinpanah F. Predictive Factors of Cholelithiasis After Prophylactic Administration of Ursodeoxycholic Acid Following Laparoscopic Bariatric Surgery: Tehran Obesity Treatment Study. Obes Surg 2021. [PMID: 34816356 DOI: 10.1007/s11695-021-05777-0] [Reference Citation Analysis]
21 Andrés-Imaz A, Martí-Gelonch L, Eizaguirre-Letamendia E, Asensio-Gallego JI, Enríquez-Navascués JM. Incidence and risk factors for de novo cholelithiasis after bariatric surgery. Cir Esp (Engl Ed) 2020:S0009-739X(20)30352-3. [PMID: 33334553 DOI: 10.1016/j.ciresp.2020.10.021] [Reference Citation Analysis]
22 Meadows V, Kennedy L, Kundu D, Alpini G, Francis H. Bile Acid Receptor Therapeutics Effects on Chronic Liver Diseases. Front Med (Lausanne) 2020;7:15. [PMID: 32064266 DOI: 10.3389/fmed.2020.00015] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
23 Chalklin CG, Ryan Harper EG, Beamish AJ. Metabolic and Bariatric Surgery in Adolescents. Curr Obes Rep 2021;10:61-9. [PMID: 33725324 DOI: 10.1007/s13679-021-00423-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
24 Choi JH, Lee SH, Cho IR, Paik WH, Ryu JK, Kim YT. Ursodeoxycholic acid for the prevention of gallstone and subsequent cholecystectomy following gastric surgery: A systematic review and meta-analysis. J Hepatobiliary Pancreat Sci 2021;28:409-18. [PMID: 33768730 DOI: 10.1002/jhbp.946] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
25 Hering I, Stier C, Seyfried F. [Bariatric surgery: Expectations and therapeutic goals-a contradiction?]. Chirurg 2018;89:597-604. [PMID: 29947918 DOI: 10.1007/s00104-018-0662-x] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
26 Guzmán HM, Sepúlveda M, Rosso N, San Martin A, Guzmán F, Guzmán HC. Incidence and Risk Factors for Cholelithiasis After Bariatric Surgery. OBES SURG 2019;29:2110-4. [DOI: 10.1007/s11695-019-03760-4] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 4.3] [Reference Citation Analysis]
27 Huang D, Joo H, Song N, Cho S, Kim W, Shin A. Association between gallstones and the risk of biliary tract cancer: a systematic review and meta-analysis. Epidemiol Health 2021;43:e2021011. [PMID: 33541011 DOI: 10.4178/epih.e2021011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Doden H, Sallam LA, Devendran S, Ly L, Doden G, Daniel SL, Alves JMP, Ridlon JM. Metabolism of Oxo-Bile Acids and Characterization of Recombinant 12α-Hydroxysteroid Dehydrogenases from Bile Acid 7α-Dehydroxylating Human Gut Bacteria. Appl Environ Microbiol 2018;84:e00235-18. [PMID: 29549099 DOI: 10.1128/AEM.00235-18] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
29 Guman MS, Haal S, de Brauw LM, Hutten BA, Nieuwdorp M, Nuijen B, Schouten R, van Veen RN, Dijkgraaf MG, Voermans RP, Gerdes VE. Factors associated with adherence to ursodeoxycholic acid or placebo in patients after bariatric surgery. Surgery for Obesity and Related Diseases 2022. [DOI: 10.1016/j.soard.2022.02.010] [Reference Citation Analysis]
30 Coupaye M, Calabrese D, Sami O, Siauve N, Ledoux S. Effectiveness of Ursodeoxycholic Acid in the Prevention of Cholelithiasis After Sleeve Gastrectomy. Obes Surg 2019;29:2464-9. [PMID: 30945151 DOI: 10.1007/s11695-019-03862-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
31 Sneineh MA, Harel L, Elnasasra A, Razin H, Rotmensh A, Moscovici S, Kais H, Shirin H. Increased Incidence of Symptomatic Cholelithiasis After Bariatric Roux-En-Y Gastric Bypass and Previous Bariatric Surgery: a Single Center Experience. Obes Surg 2020;30:846-50. [PMID: 31901127 DOI: 10.1007/s11695-019-04366-6] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 14.0] [Reference Citation Analysis]
32 Andrés-Imaz A, Martí-Gelonch L, Eizaguirre-Letamendia E, Asensio-Gallego JI, Enríquez-Navascués JM. Incidence and risk factors for de novo cholelithiasis after bariatric surgery. Cir Esp (Engl Ed) 2021;99:648-54. [PMID: 34635453 DOI: 10.1016/j.cireng.2021.09.010] [Reference Citation Analysis]
33 Haal S, Guman MSS, de Brauw LM, van Veen RN, Schouten R, Fockens P, Gerdes VEA, Dijkgraaf MGW, Voermans RP. Ursodeoxycholic acid for the prevention of symptomatic gallstone disease after bariatric surgery: statistical analysis plan for a randomised controlled trial (UPGRADE trial). Trials 2020;21:676. [PMID: 32703246 DOI: 10.1186/s13063-020-04605-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
34 Stenberg E, Dos Reis Falcão LF, O'Kane M, Liem R, Pournaras DJ, Salminen P, Urman RD, Wadhwa A, Gustafsson UO, Thorell A. Guidelines for Perioperative Care in Bariatric Surgery: Enhanced Recovery After Surgery (ERAS) Society Recommendations: A 2021 Update. World J Surg 2022. [PMID: 34984504 DOI: 10.1007/s00268-021-06394-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 10.0] [Reference Citation Analysis]
35 El shafey HE, Elgohary H, El Azawy M, Omar W. The incidence of gall stones after bariatric surgery and its association with weight loss. International Journal of Surgery Open 2021;33:100340. [DOI: 10.1016/j.ijso.2021.100340] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
36 Mechanick JI, Apovian C, Brethauer S, Timothy Garvey W, Joffe AM, Kim J, Kushner RF, Lindquist R, Pessah-Pollack R, Seger J, Urman RD, Adams S, Cleek JB, Correa R, Figaro MK, Flanders K, Grams J, Hurley DL, Kothari S, Seger MV, Still CD. Clinical Practice Guidelines for the Perioperative Nutrition, Metabolic, and Nonsurgical Support of Patients Undergoing Bariatric Procedures - 2019 Update: Cosponsored by American Association of Clinical Endocrinologists/American College of Endocrinology, The Obesity Society, American Society for Metabolic and Bariatric Surgery, Obesity Medicine Association, and American Society of Anesthesiologists. Obesity (Silver Spring) 2020;28:O1-O58. [PMID: 32202076 DOI: 10.1002/oby.22719] [Cited by in Crossref: 44] [Cited by in F6Publishing: 35] [Article Influence: 44.0] [Reference Citation Analysis]
37 Haal S, Guman MSS, Boerlage TCC, Acherman YIZ, de Brauw LM, Bruin S, de Castro SMM, van Hooft JE, van de Laar AWJM, Moes DE, Schouten M, Schouten R, van Soest EJ, van Veen RN, de Vries CEE, Fockens P, Dijkgraaf MGW, Gerdes VEA, Voermans RP. Ursodeoxycholic acid for the prevention of symptomatic gallstone disease after bariatric surgery (UPGRADE): a multicentre, double-blind, randomised, placebo-controlled superiority trial. Lancet Gastroenterol Hepatol 2021;6:993-1001. [PMID: 34715031 DOI: 10.1016/S2468-1253(21)00301-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 9.0] [Reference Citation Analysis]
38 Sakran N, Dar R, Assalia A, Neeman Z, Farraj M, Sherf-Dagan S, Gralnek IM, Hazzan R, Mokary SE, Nevo-Aboody H, Dola T, Kaplan U, Hershko D. The use of Ursolit for gallstone prophylaxis following bariatric surgery: a randomized-controlled trial. Updates Surg 2020;72:1125-33. [PMID: 32666477 DOI: 10.1007/s13304-020-00850-2] [Cited by in Crossref: 7] [Article Influence: 3.5] [Reference Citation Analysis]
39 Ying J, Dai S, Fu R, Hong J, Dai C, Jin Q. Effect of ursodeoxycholic acid on gallstone formation after bariatric surgery: An updated meta-analysis. Obesity (Silver Spring) 2022. [PMID: 35475596 DOI: 10.1002/oby.23427] [Reference Citation Analysis]
40 Nosrati SS, Pazouki A, Sabzikarian M, Pakaneh M, Kabir A, Kermansaravi M. Can Omentopexy Reduce the Incidence of Gastroesophageal Reflux Disease After Laparoscopic Sleeve Gastrectomy. Obes Surg 2021;31:274-81. [PMID: 32809139 DOI: 10.1007/s11695-020-04923-4] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
41 Mechanick JI, Apovian C, Brethauer S, Garvey WT, Joffe AM, Kim J, Kushner RF, Lindquist R, Pessah-Pollack R, Seger J, Urman RD, Adams S, Cleek JB, Correa R, Figaro MK, Flanders K, Grams J, Hurley DL, Kothari S, Seger MV, Still CD. Clinical practice guidelines for the perioperative nutrition, metabolic, and nonsurgical support of patients undergoing bariatric procedures - 2019 update: cosponsored by American Association of Clinical Endocrinologists/American College of Endocrinology, The Obesity Society, American Society for Metabolic & Bariatric Surgery, Obesity Medicine Association, and American Society of Anesthesiologists. Surg Obes Relat Dis 2020;16:175-247. [PMID: 31917200 DOI: 10.1016/j.soard.2019.10.025] [Cited by in Crossref: 69] [Cited by in F6Publishing: 58] [Article Influence: 23.0] [Reference Citation Analysis]
42 Mahawar KK, Hayes C, Graham YN. Ascertaining Areas for Long-Term Follow-Up of Bariatric Surgical Patients for Primary Care: A Narrative Review. Bariatric Surgical Practice and Patient Care 2020;15:63-72. [DOI: 10.1089/bari.2019.0023] [Reference Citation Analysis]
43 Mechanick JI, Apovian C, Brethauer S, Garvey WT, Joffe AM, Kim J, Kushner RF, Richard Lindquist, Pessah-pollack R, Seger J, Urman RD, Adams S, Cleek JB, Correa R, Figaro MK, Flanders K, Grams J, Hurley DL, Kothari S, Seger MV, Still CD. Clinical Practice Guidelines For The Perioperative Nutrition, Metabolic, and Nonsurgical Support of Patients Undergoing Bariatric Procedures – 2019 Update: Cosponsored By American Association of Clinical Endocrinologists/American College of Endocrinology, The Obesity Society, American Society For Metabolic & Bariatric Surgery, Obesity Medicine Association, and American Society of Anesthesiologists. Endocrine Practice 2019;25:1-75. [DOI: 10.4158/gl-2019-0406] [Cited by in Crossref: 39] [Cited by in F6Publishing: 31] [Article Influence: 13.0] [Reference Citation Analysis]
44 Cabrera D, Arab JP, Arrese M. UDCA, NorUDCA, and TUDCA in Liver Diseases: A Review of Their Mechanisms of Action and Clinical Applications. In: Fiorucci S, Distrutti E, editors. Bile Acids and Their Receptors. Cham: Springer International Publishing; 2019. pp. 237-64. [DOI: 10.1007/164_2019_241] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
45 Nagem R, Alberti LR, de Campos-Lobato LF. Is It Safe to Recommend Cholecystectomy Whenever Gallstones Develop After Bariatric Surgery? Obes Surg 2021;31:179-84. [PMID: 32710368 DOI: 10.1007/s11695-020-04862-0] [Reference Citation Analysis]